Clinical Trial Update: Dose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 dose-finding study of a three-drug combination (capecitabine, lapatinib, vinorelbine) in metastatic breast cancer with HER2 positivity; the trial has be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (Xeloda) (Capecitabine)
• Lapatinib (Tykerb) (lapatinib)
• Vinorelbine (Navelbine) (vinorelbine tartrate)

Snippet

Sponsor: Sponsor GmbH | Conditions: Metastatic Breast Cancer, HER2 Positive | Phase 1 | Status: TERMINATED